US Stock MarketDetailed Quotes

SIGY SIGYN THERAPEUTICS INC

Watchlist
  • 3.150000
  • 0.0000000.00%
15min DelayClose Dec 17 16:00 ET
3.86MMarket Cap-0.84P/E (TTM)

SIGYN THERAPEUTICS INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
55.00%-163.81K
44.39%-182.79K
58.12%-235.61K
24.42%-1.38M
71.69%-127.89K
30.55%-364.05K
16.73%-328.69K
-22.41%-562.57K
-3.16%-1.83M
18.30%-451.77K
Net income from continuing operations
-32.15%-1.2M
-19.26%-862.38K
43.47%-758.09K
-41.51%-4.15M
-36.92%-1.18M
-24.67%-905.73K
-8.52%-723.12K
-97.78%-1.34M
2.49%-2.93M
30.01%-858.94K
Operating gains losses
----
----
----
---352.97K
---126.04K
---2.57K
---208.56K
---15.81K
----
----
Depreciation and amortization
-32.39%1.36K
-47.92%1.36K
-41.76%1.52K
-15.29%8.86K
-38.43%1.61K
-22.94%2.02K
-0.15%2.62K
0.42%2.62K
-45.41%10.45K
1.87%2.62K
Other non cash items
123.97%593.1K
-27.49%259.01K
-84.83%126.61K
160.98%2.04M
51.09%584.75K
37.35%264.81K
167.49%357.18K
1,113.23%834.45K
10.25%782.11K
132.00%387.01K
Change In working capital
56.88%376.38K
85.58%381.72K
544.44%356.85K
176.90%850.1K
2,663.52%484.78K
3,360.04%239.92K
51.87%205.69K
-154.59%-80.29K
999.02%307.01K
156.19%17.54K
-Change in payables and accrued expense
62.88%391.77K
70.08%374.41K
787.73%353.71K
182.67%895.76K
2,142.45%486.52K
829.70%240.53K
28.22%220.14K
-132.87%-51.43K
1,006.29%316.9K
159.34%21.7K
-Change in other current assets
-1,424.34%-11.59K
159.05%8.86K
116.95%4.78K
-350.30%-44.43K
55.50%-2.09K
-97.84%875
57.70%-15K
-177.47%-28.22K
56.70%-9.87K
-118.43%-4.69K
-Change in other current liabilities
-155.75%-3.8K
-378.38%-1.55K
-157.50%-1.65K
-5,771.43%-1.23K
-36.52%339
-167.93%-1.49K
170.34%555
-181.12%-640
-100.09%-21
102.66%534
Cash from discontinued investing activities
Operating cash flow
55.00%-163.81K
44.39%-182.79K
58.12%-235.61K
24.42%-1.38M
71.69%-127.89K
30.55%-364.05K
16.73%-328.69K
-22.41%-562.57K
-3.16%-1.83M
18.30%-451.77K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
97.06%-860
0
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
97.06%-860
--0
Cash from discontinued investing activities
Investing cash flow
----
----
--0
--0
----
----
----
--0
97.06%-860
--0
Financing cash flow
Cash flow from continuing financing activities
-32.11%274.96K
578.67%203.6K
-70.71%256.76K
-7.47%1.39M
-82.64%75K
-25.69%405K
-90.67%30K
338.27%876.54K
-27.26%1.5M
8.00%432K
Net issuance payments of debt
-22.68%301.53K
--218.6K
-71.46%251.76K
-16.27%1.31M
-91.25%40K
-33.33%390K
--0
341.00%882K
703.59%1.57M
--457K
Net other financing activities
-277.16%-26.57K
-150.00%-15K
191.64%5K
208.83%74.54K
240.00%35K
137.50%15K
--30K
---5.46K
---68.5K
---25K
Cash from discontinued financing activities
Financing cash flow
-32.11%274.96K
578.67%203.6K
-70.71%256.76K
-7.47%1.39M
-82.64%75K
-25.69%405K
-90.67%30K
338.27%876.54K
-27.26%1.5M
8.00%432K
Net cash flow
Beginning cash position
126.99%53.64K
-89.81%32.84K
39.90%11.69K
-97.55%8.36K
129.65%64.58K
224.14%23.63K
296.05%322.33K
-97.55%8.36K
303.97%340.96K
-94.41%28.12K
Current changes in cash
171.41%111.14K
106.97%20.81K
-93.26%21.15K
101.00%3.33K
-167.59%-52.89K
96.58%40.95K
-303.13%-298.69K
220.96%313.97K
-229.64%-332.6K
87.80%-19.77K
End cash Position
155.15%164.79K
126.99%53.64K
-89.81%32.84K
39.90%11.69K
39.90%11.69K
129.65%64.58K
224.14%23.63K
296.05%322.33K
-97.55%8.36K
-97.55%8.36K
Free cash flow
55.00%-163.81K
44.39%-182.79K
58.12%-235.61K
24.46%-1.38M
71.69%-127.89K
30.55%-364.05K
16.91%-328.69K
-22.41%-562.57K
-1.53%-1.83M
19.62%-451.77K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 55.00%-163.81K44.39%-182.79K58.12%-235.61K24.42%-1.38M71.69%-127.89K30.55%-364.05K16.73%-328.69K-22.41%-562.57K-3.16%-1.83M18.30%-451.77K
Net income from continuing operations -32.15%-1.2M-19.26%-862.38K43.47%-758.09K-41.51%-4.15M-36.92%-1.18M-24.67%-905.73K-8.52%-723.12K-97.78%-1.34M2.49%-2.93M30.01%-858.94K
Operating gains losses ---------------352.97K---126.04K---2.57K---208.56K---15.81K--------
Depreciation and amortization -32.39%1.36K-47.92%1.36K-41.76%1.52K-15.29%8.86K-38.43%1.61K-22.94%2.02K-0.15%2.62K0.42%2.62K-45.41%10.45K1.87%2.62K
Other non cash items 123.97%593.1K-27.49%259.01K-84.83%126.61K160.98%2.04M51.09%584.75K37.35%264.81K167.49%357.18K1,113.23%834.45K10.25%782.11K132.00%387.01K
Change In working capital 56.88%376.38K85.58%381.72K544.44%356.85K176.90%850.1K2,663.52%484.78K3,360.04%239.92K51.87%205.69K-154.59%-80.29K999.02%307.01K156.19%17.54K
-Change in payables and accrued expense 62.88%391.77K70.08%374.41K787.73%353.71K182.67%895.76K2,142.45%486.52K829.70%240.53K28.22%220.14K-132.87%-51.43K1,006.29%316.9K159.34%21.7K
-Change in other current assets -1,424.34%-11.59K159.05%8.86K116.95%4.78K-350.30%-44.43K55.50%-2.09K-97.84%87557.70%-15K-177.47%-28.22K56.70%-9.87K-118.43%-4.69K
-Change in other current liabilities -155.75%-3.8K-378.38%-1.55K-157.50%-1.65K-5,771.43%-1.23K-36.52%339-167.93%-1.49K170.34%555-181.12%-640-100.09%-21102.66%534
Cash from discontinued investing activities
Operating cash flow 55.00%-163.81K44.39%-182.79K58.12%-235.61K24.42%-1.38M71.69%-127.89K30.55%-364.05K16.73%-328.69K-22.41%-562.57K-3.16%-1.83M18.30%-451.77K
Investing cash flow
Cash flow from continuing investing activities 00097.06%-8600
Net PPE purchase and sale --------------0----------------97.06%-860--0
Cash from discontinued investing activities
Investing cash flow ----------0--0--------------097.06%-860--0
Financing cash flow
Cash flow from continuing financing activities -32.11%274.96K578.67%203.6K-70.71%256.76K-7.47%1.39M-82.64%75K-25.69%405K-90.67%30K338.27%876.54K-27.26%1.5M8.00%432K
Net issuance payments of debt -22.68%301.53K--218.6K-71.46%251.76K-16.27%1.31M-91.25%40K-33.33%390K--0341.00%882K703.59%1.57M--457K
Net other financing activities -277.16%-26.57K-150.00%-15K191.64%5K208.83%74.54K240.00%35K137.50%15K--30K---5.46K---68.5K---25K
Cash from discontinued financing activities
Financing cash flow -32.11%274.96K578.67%203.6K-70.71%256.76K-7.47%1.39M-82.64%75K-25.69%405K-90.67%30K338.27%876.54K-27.26%1.5M8.00%432K
Net cash flow
Beginning cash position 126.99%53.64K-89.81%32.84K39.90%11.69K-97.55%8.36K129.65%64.58K224.14%23.63K296.05%322.33K-97.55%8.36K303.97%340.96K-94.41%28.12K
Current changes in cash 171.41%111.14K106.97%20.81K-93.26%21.15K101.00%3.33K-167.59%-52.89K96.58%40.95K-303.13%-298.69K220.96%313.97K-229.64%-332.6K87.80%-19.77K
End cash Position 155.15%164.79K126.99%53.64K-89.81%32.84K39.90%11.69K39.90%11.69K129.65%64.58K224.14%23.63K296.05%322.33K-97.55%8.36K-97.55%8.36K
Free cash flow 55.00%-163.81K44.39%-182.79K58.12%-235.61K24.46%-1.38M71.69%-127.89K30.55%-364.05K16.91%-328.69K-22.41%-562.57K-1.53%-1.83M19.62%-451.77K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data